Witnessing the stock’s movement on the chart, on May 03, 2021, Abeona Therapeutics Inc. (NASDAQ: ABEO) set off with pace as it heaved 14.69% to $2.03. During the day, the stock rose to $2.04 and sunk to $1.82 before settling in for the price of $1.77 at the close. Taking a more long-term approach, ABEO posted a 52-week range of $0.99-$3.79.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 57.30%. Meanwhile, its Annual Earning per share during the time was -11.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 40.00%. This publicly-traded company’s shares outstanding now amounts to $91.06 million, simultaneously with a float of $84.39 million. The organization now has a market capitalization sitting at $190.84 million. At the time of writing, stock’s 50-day Moving Average stood at $1.92, while the 200-day Moving Average is $1.93.
If we measure the efficiency of the company that is accounted for 76 employees. It has generated 131,579 per worker during the last fiscal year. For the Profitability, stocks operating margin was -485.04 and Pretax Margin of -842.34.
Abeona Therapeutics Inc. (ABEO) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Abeona Therapeutics Inc.’s current insider ownership accounts for 0.90%, in contrast to 34.50% institutional ownership. According to the most recent insider trade that took place on Apr 05, this organization’s Chief Accounting Officer sold 35,000 shares at the rate of 1.80, making the entire transaction reach 62,846 in total value, affecting insider ownership by 191,291. Preceding that transaction, on Apr 01, Company’s Chief Accounting Officer sold 20,445 for 1.85, making the whole transaction’s value amount to 37,866. This particular insider is now the holder of 226,291 in total.
Abeona Therapeutics Inc. (ABEO) Earnings and Revenue Records
As on 12/30/2020, Multinational firm has announced its last quarter scores, in which it reported -$0.17 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.1) by -$0.07. This company achieved a net margin of -842.34 while generating a return on equity of -59.96. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
Abeona Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 40.00% and is forecasted to reach -0.69 in the upcoming year.
Abeona Therapeutics Inc. (NASDAQ: ABEO) Trading Performance Indicators
Let’s observe the current performance indicators for Abeona Therapeutics Inc. (ABEO). It’s Quick Ratio in the last reported quarter now stands at 2.30. The Stock has managed to achieve an average true range (ATR) of 0.15. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 19.08.
In the same vein, ABEO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.91, a figure that is expected to reach -0.19 in the next quarter, and analysts are predicting that it will be -0.69 at the market close of one year from today.
Technical Analysis of Abeona Therapeutics Inc. (ABEO)
Going through the that latest performance of [Abeona Therapeutics Inc., ABEO]. Its last 5-days volume of 2.28 million was inferior to the volume of 3.53 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 88.74% While, its Average True Range was 0.16.
Raw Stochastic average of Abeona Therapeutics Inc. (ABEO) in the period of the previous 100 days is set at 27.72%, which indicates a major fall in contrast to 98.54% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 86.24% that was lower than 99.81% volatility it exhibited in the past 100-days period.